MedTrace Logo

Air Optix® Night and Day® Aqua Daily Wear

NCT05976750 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2024-08-09

No results posted yet for this study

Summary

The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix® Night and Day® Aqua (AONDA) contact lenses in a real-world setting when worn as daily wear for vision correction.

Conditions

  • Refractive Errors
  • Myopia
  • Hyperopia

Interventions

DEVICE

Lotrafilcon A contact lenses

CE-marked silicone hydrogel contact lenses for daily wear use

DEVICE

Balafilcon A contact lenses

CE-marked silicone hydrogel contact lenses for daily wear use

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Clinical Trial Lead, CRD Vision Care · Alcon Research, LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-03
Primary Completion
2024-07-30
Completion
2024-07-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05976750 on ClinicalTrials.gov